Measuring the impact of antimicrobial stewardship programs

References

• Goossens H. Antibiotic consumption and link to resistance. Clin Microbiol Infect. 2009;15(Suppl 3):12–15.
   PubMed Web of Science ®Google Scholar
• Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev. 2011;24:718–733.
   PubMed Web of Science ®Google Scholar
• Renwick MJ, Simpkin V, Mossialos E. International and European initiatives targeting innovation in antibiotic drug discovery and development. The need of a one health – one Europe – one world framework. Den Haag, Netherlands: Dutch Ministry of Health; 2016. p. 1–93.
   Google Scholar
• World Health Organization. The evolving threat of antimicrobial resistance – options for action. Geneva, Switzerland; 2012; [cited 2016 Feb 22]. Available from: http://apps.who.int/iris/bitstream/10665/44812/1/9789241503181_eng.pdf
   Google Scholar
• Dellit T, Owens R, McGowan J, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159–177.
   PubMed Web of Science ®Google Scholar
• With de K, Allerberger F, Amann S, et al. S3-Leitlinie. S3-Guideline: strategies to enhance rational use of antibiotics in hospital. Infection. 2016. doi:10.1007/s15010-016-0885-z. [Epub ahead of print]
   Web of Science ®Google Scholar
• SWAB. De kwaliteit van het antibioticabeleid in Nederland; 2012; [cited 2016 Feb 22]. Available from: http://www.swab.nl/swab/cms3.nsf/uploads/5FD2BE2700E8B433C1257A680028D9F0/$FILE/visiedoc%20SWAB%20vs%2021%20junifinal.pdf
   Google Scholar
• Davey P, Brown E, Charani E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2013;4:CD003543.
   PubMed Web of Science ®Google Scholar
• Schuts EC, Hulscher MEJL, Mouton JW, et al. A systematic review and meta-analysis of current evidence on hospital Antimicrobial Stewardship objectives. Lancet Infect Dis. 2016. pii:S1473-3099(16)00065-7. doi:10.1016/S1473-3099(16)00065-7. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• McGowan J. Antimicrobial stewardship–the state of the art in 2011: focus on outcome and methods. Infect Control Hospital Epidemiol. 2012;33:331–337.
   PubMed Web of Science ®Google Scholar
• Morris AM. Antimicrobial stewardship programs: appropriate measures and metrics to study their impact. Curr Treat Options Infect Dis. 2014;6:101–112.
   PubMedGoogle Scholar
• Evans SR, Rubin D, Follmann D, et al. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR). Clin Infect Dis. 2015;61:800–806.
   PubMed Web of Science ®Google Scholar
• McGowan JE, Gerding DN. Does antibiotic restriction prevent resistance? New Horiz. 1996;4:370–376.
   PubMedGoogle Scholar
• Howard P, Pulcini C, Levy Hara G, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. J Antimicrob Chemother. 2015;70:1245–1255.
   PubMed Web of Science ®Google Scholar
• Lammie SL, Hughes JM. Antimicrobial resistance, food safety, and one health: the need for convergence. Ann Rev Food Sci Technol. 2016;7:287–312.
   PubMed Web of Science ®Google Scholar
• Dik JH, Poelman R, Friedrich AW, et al. An integrated stewardship model: antimicrobial, infection prevention and diagnostic (AID). Future Microbiol. 2016;11:93–102.
   PubMed Web of Science ®Google Scholar
• Donker T, Wallinga J, Grundmann H. Patient referral patterns and the spread of hospital-acquired infections through national health care networks. PLoS Comput Biol. 2010;6(3):e1000715.
   PubMed Web of Science ®Google Scholar
• Ciccolini M, Donker T, Köck RR, et al. Infection prevention in a connected world: the case for a regional approach. Int J Med Microbiol. 2013;303:380–387.
   PubMed Web of Science ®Google Scholar
• Müller J, Voss A, Köck R, et al. Cross-border comparison of the Dutch and German guidelines on multidrug-resistant gram-negative microorganisms. Antimicrob Resist Infect Control. 2015;4:7.
   PubMed Web of Science ®Google Scholar
• Caliendo AM, Gilbert DN, Ginocchio CC, et al. Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013;57(Suppl 3):S139S170.
   Web of Science ®Google Scholar
• Buehler SS, Madison B, Snyder SR, et al. Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev. 2016;29:59–103.
   PubMed Web of Science ®Google Scholar
• Rogers BB, Shankar P, Jerris RC, et al. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med. 2015;139:636–641.
   PubMed Web of Science ®Google Scholar
• Tacconelli E, De Angelis G, de Waure C, et al. Rapid screening tests for meticillin-resistant Staphylococcus aureus at hospital admission: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(9):546–554.
   PubMed Web of Science ®Google Scholar
• Wassenberg M, Kluytmans J, Erdkamp S, et al. Costs and benefits of rapid screening of methicillin-resistant Staphylococcus aureus carriage in intensive care units: a prospective multicenter study. Crit Care. 2012;16(1):R22.
   PubMed Web of Science ®Google Scholar
• Mather CA, Werth BJ, Sivagnanam S, et al. Rapid detection of vancomycin-intermediate Staphylococcus aureus by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2016;54(4):883–890.
   PubMed Web of Science ®Google Scholar
• Evans SR, Hujer AM, Jiang H, et al. Rapid molecular diagnostics, antibiotic treatment decisions, and developing approaches to inform empiric therapy: PRIMERS I and II. Clin Infect Dis. 2016;62:181–189.
   PubMed Web of Science ®Google Scholar
• Bauer KA, West JE, Balada-Llasat JM, et al. An antimicrobial stewardship program’s impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. Aureus blood culture test in patients with S. aureus bacteremia. Clin Infect Dis. 2010;51(9):1074–1080.
   PubMed Web of Science ®Google Scholar
• Clerc O, Prod’hom G, Senn L, et al. Matrix-assisted laser desorption ionization time-of-flight mass spectrometry and PCR-based rapid diagnosis of Staphylococcus aureus bacteraemia. Clin Microbiol Infect. 2014;20(4):355–360.
   PubMed Web of Science ®Google Scholar
• Banerjee R, Teng CB, Cunningham SA, et al. Randomized trial of rapid multiplex polymerase chain reaction-based blood culture identification and susceptibility testing. Clin Infect Dis. 2015;61(7):1071–1080.
   PubMed Web of Science ®Google Scholar
• Nobre V, Harbarth S, Graf JD, et al. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Resp Crit Care Med. 2009;177(5):498–505.
   Web of Science ®Google Scholar
• Bouadma L, Luyt CE, Tubach F, et al. Use of procalcitonin to reduce patients’ exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet. 2010;375(9713):463–474.
   PubMed Web of Science ®Google Scholar
• Schuetz P, Müller B, Christ-Crain M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2012;9:CD007498.
   PubMed Web of Science ®Google Scholar
• de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016. pii:S1473-3099(16)00053-0. doi:10.1016/S1473-3099(16)00053-0. [Epub ahead of print]
   Web of Science ®Google Scholar
• Popowitch EB, O’Neill SS, Miller MB. Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses. J Clin Microbiol. 2013;51(5):1528–1533.
   PubMed Web of Science ®Google Scholar
• Plantinga NL, Bonten MJ. Selective decontamination and antibiotic resistance in ICUs. Crit Care. 2015;19:259.
   PubMed Web of Science ®Google Scholar
• Daneman N, Sarwar S, Fowler RA, et al.; SuDDICU Canadian Study Group. Effect of selective decontamination on antimicrobial resistance in intensive care units: a systematic review and meta-analysis. Lancet Infect Dis. 2013;13:328–341.
   PubMed Web of Science ®Google Scholar
• Dik JH, Vemer P, Friedrich AW, et al. Financial evaluations of antibiotic stewardship programs – a systematic review. Front Microbiol. 2015;6:317.
   PubMed Web of Science ®Google Scholar
• Coulter S, Merollini K, Roberts JA, et al. The need for cost-effectiveness analyses of antimicrobial stewardship programmes: a structured review. Int J Antimicrob Agents. 2015;46:140–149.
   PubMed Web of Science ®Google Scholar
• Lesprit P, Landelle C, Brun-Buisson C. Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial. Clin Microbiol Infect. 2013;19:91–97.
   PubMed Web of Science ®Google Scholar
• Fleet E, Gopal Rao G, Patel B, et al. Impact of implementation of a novel antimicrobial stewardship tool on antibiotic use in nursing homes: a prospective cluster randomized control pilot study. J Antimicrob Chemother. 2014;69:2265–2273.
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Torrance GW, et al. Cost analysis. In: Drummond MF, editor. Methords for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005. p. 65–101.
   Google Scholar
• Nathwani D, Sneddon J, Patton A, et al. Antimicrobial stewardship in Scotland: impact of a national programme. Antimicrob Resist Infect Control. 2012;1(1):7.
   PubMed Web of Science ®Google Scholar
• Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother. 2014;69:881–891.
   PubMed Web of Science ®Google Scholar
• Schulz LT, Fox BC, Polk RE. Can the antibiogram be used to assess microbiologic outcomes after antimicrobial stewardship interventions? A critical review of the literature. Pharmacotherapy. 2012;32:668–676.
   PubMed Web of Science ®Google Scholar
• Donker T, Ciccolini M, Wallinga J, et al. [Analysis of patient flows: basis for regional control of antibiotic resistance]. Ned Tijdschr Geneeskd. 2015;159:A8468. Dutch.
   PubMedGoogle Scholar
• Tacconelli E, Cataldo MA, Paul M, et al. STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardship. BMJ Open. 2016;6:e010134.
   Web of Science ®Google Scholar
• Health Council of the Netherlands. Antibiotics in hospitals: prophylaxix and antibiotic stewardship. Vol. 12. The Hague, Netherlands: Health Council of the Netherlands; 2015. p. 1–64; [cited 2016 Apr 5]. Available from: https://www.gezondheidsraad.nl/sites/default/files/201512_antibiotica_in_ziekenhuizen.pdf
   Google Scholar
• Nathwani D, Lawson W, Dryden M, et al. Implementing criteria-based early switch/early discharge programmes: a European perspective. Clin Microbiol Infect. 2015;21:47–55.
   PubMed Web of Science ®Google Scholar
• Tan C, Ritchie M, Alldred J, et al. Validating hospital antibiotic purchasing data as a metric of inpatient antibiotic use. J Antimicrob Chemother. 2016;71:547–553.
   PubMed Web of Science ®Google Scholar
• De With K, Bestehorn H, Steib Bauert M, et al. Comparison of defined versus recommended versus prescribed daily doses for measuring hospital antibiotic consumption. Infection. 2009;37:349–352.
   PubMed Web of Science ®Google Scholar
• Fortin E, Fontela PS, Manges AR, et al. Measuring antimicrobial use in hospitalized patients: a systematic review of available measures applicable to paediatrics. J Antimicrob Chemother. 2014;69(6):1447–1456.
   PubMed Web of Science ®Google Scholar
• Gagliotti C, Ricchizzi E, Buttazzi R, et al. Hospital statistics for antibiotics: defined versus prescribed daily dose. Infection. 2014;42:869–873.
   PubMed Web of Science ®Google Scholar
• Polk RE, Fox C, Mahoney A, et al. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664–670.
   PubMed Web of Science ®Google Scholar
• DePestel DD, Eiland EH 3rd, Lusardi K, et al. Assessing appropriateness of antimicrobial therapy: in the eye of the interpreter. Clin Infect Dis. 2014;59(Suppl 3):S154S161.
   Web of Science ®Google Scholar
• Spoorenberg V, Hulscher MEJL, Akkermans R, et al. Appropriate antibiotic use for patients with urinary tract infections reduces length of hospital stay. Clin Infect Dis. 2014;58:164–169.
   PubMed Web of Science ®Google Scholar
• Stewardson AJ, Harbarth S, Graves N; TIMBER Study Group. Valuation of hospital bed-days released by infection control programs: a comparison of methods. Infect Control Hosp Epidemiol. 2014;35(10):1294–1297.
   PubMed Web of Science ®Google Scholar
• Brüggemann RJ, Aarnoutse RE. Fundament and prerequisites for the application of an antifungal TDM service. Curr Fungal Infect Rep. 2015;9:122–129.
   PubMedGoogle Scholar
• Valerio M, Muñoz P, Rodriguez CG, et al. Antifungal stewardship in a tertiary-care institution: a bedside intervention. Clin Microbiol Infect. 2015;21:1–9.
   PubMed Web of Science ®Google Scholar
• Muñoz P, Valerio M, Vena A, et al. Antifungal stewardship in daily practice and health economic implications. Mycoses. 2015;58:14–25.
   PubMed Web of Science ®Google Scholar
• van Limburg M, Sinha B, Lo-Ten-Foe JR, et al. Evaluation of early implementations of antibiotic stewardship program initiatives in nine Dutch hospitals. Antimicrob Res Infect Control. 2014;3:33.
   PubMed Web of Science ®Google Scholar